Pro-angiogenic cytokines and their role in tumor angiogenesis |
| |
Authors: | Gera Neufeld Ofra Kessler |
| |
Affiliation: | (1) Cancer and Vascular Biology Research Center, Rappaport Research Institute in the Medical Sciences, The Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, 1 Efron St., P. O. Box 9679, Haifa, 31096, Israel |
| |
Abstract: | The development of solid tumors depends upon an adequate supply of blood. This can be achieved by way of co-option of preexisting blood vessels and by the induction of angiogenesis. During the past 30 years, tumor angiogenesis had been found to play a crucial role in the progression of solid tumors. Tumor angiogenesis was found to be induced by a variety of pro-angiogenic cytokines of which the best characterized is vascular endothelial growth factor (VEGF). Indeed, the first FDA approved anti-angiogenic drug for the treatment of cancer is AvastinTM, a neutralizing antibdy directed against VEGF. This review focuses on cytokines which have been reported to induce tumor angiogenesis. |
| |
Keywords: | Tumor progression Tumorigenesis Review Angiogenesis Lymphangiogenesis cytokines Metastasis Tumor angiogenesis |
本文献已被 PubMed SpringerLink 等数据库收录! |
|